CymaBay Therapeutics (NASDAQ:CBAY)

CymaBay Therapeutics (NASDAQ:CBAY)


Share Price
$ 6.54
Change
0.07 (1.08 %)
Market Cap
$449.27 m
Proactive Investors - Run By Investors For Investors

CymaBay Therapeutics

We are a clinical-stage biopharmaceutical company focused on developing and providing access to innovative therapies for patients with liver and other chronic diseases with high unmet medical need.


Our lead asset, Seladelpar, is a potent, selective, orally active PPARδ agonist currently in development for the treatment of patients with the autoimmune liver disease, primary biliary...

EPIC: CBAY
Market: NASDAQ:CBAY
52-week High/Low: $14.00 / $4.82
Sector: Pharma & Biotech
Market Cap: $449.27 m
Website: www.cymabay.com
col 3
col 4
col 5
col 6

CymaBay Therapeutics Timeline

Market Reports Including CBAY

VIEW ALL
Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use